Search Results | Diabetes | American Diabetes Association

1-14 of 14

Sort by

Sort Order Select

Meeting Abstracts

1263-P: Adolescent Obesity and Incident Type 1 Diabetes in Young Adulthood

INBAR ZUCKER, YAIR ZLOOF, AYA BARDUGO, AVISHAI M. TSUR, MIRI LUTSKI, YARON COHEN, TALI CUKIERMAN-YAFFE, NOGA MINSKY, ESTELA DERAZNE, DORIT TZUR, CHELI MELZER COHEN, ORIT PINHAS-HAMIEL, GABRIEL CHODICK, ITAMAR RAZ, ARNON AFEK, HERTZEL C. GERSTEIN, AMIR TIROSH, GILAD TWIG

Diabetes 2022;71(Supplement_1):1263-P

DOI: https://doi.org/10.2337/db22-1263-P

Published: 01 June 2022

View article

Meeting Abstracts

788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58

AVIVIT CAHN, STEPHEN D. WIVIOTT, OFRI MOSENZON, SABINA MURPHY, ERICA L. GOODRICH, DEEPAK L. BHATT, LAWRENCE A. LEITER, DARREN K. MCGUIRE, JOHN WILDING, INGRID A. GAUSE-NILSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, ITAMAR RAZ

Diabetes 2021;70(Supplement_1):788-P

DOI: https://doi.org/10.2337/db21-788-P

Published: 01 June 2021

View article

Meeting Abstracts

303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial

Diabetes 2020;69(Supplement_1):303-OR

DOI: https://doi.org/10.2337/db20-303-OR

Published: 01 June 2020

View article

Meeting Abstracts

1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

AVIVIT CAHN, STEPHEN D. WIVIOTT, OFRI MOSENZON, SABINA MURPHY, ERICA L. GOODRICH, ILAN YANUV, ALIZA ROZENBERG, JOHN WILDING, LAWRENCE A. LEITER, DEEPAK L. BHATT, DARREN K. MCGUIRE, LEON LITWAK, ADRIAAN KOOY, INGRID A. GAUSE-NILSSON, MARTIN FREDRIKSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, ITAMAR RAZ

Diabetes 2020;69(Supplement_1):1101-P

DOI: https://doi.org/10.2337/db20-1101-P

Published: 01 June 2020

View article

Meeting Abstracts

244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

ITAMAR RAZ, STEPHEN D. WIVIOTT, ILAN YANUV, ALIZA ROZENBERG, THOMAS A. ZELNIKER, AVIVIT CAHN, HIDDO L. HEERSPINK, JAMIE P. DWYER, ERICA GOODRICH, DEEPAK L. BHATT, LAWRENCE A. LEITER, DARREN K. MCGUIRE, JOHN P. WILDING, INGRID ANNA GAUSE-NILSSON, MARTIN FREDRIKSSON, PETER A. JOHANSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, OFRI MOSENZON

Diabetes 2019;68(Supplement_1):244-OR

DOI: https://doi.org/10.2337/db19-244-OR

Published: 01 June 2019

View article

Meeting Abstracts

236-OR: Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial

OFRI MOSENZON, STEPHEN D. WIVIOTT, THOMAS A. ZELNIKER, HIDDO L. HEERSPINK, JAMIE P. DWYER, AVIVIT CAHN, INGRID ANNA GAUSE-NILSSON, ANNA MARIA LANGKILDE, MARC S. SABATINE, ITAMAR RAZ

Diabetes 2019;68(Supplement_1):236-OR

DOI: https://doi.org/10.2337/db19-236-OR

Published: 01 June 2019

View article

Meeting Abstracts

The Association between Inpatient Hyperglycemia and Thirty-Day Mortality Is Modified by Type 2 Diabetes History

HANA'A RAYYAN ASSI, BECCA S. FELDMAN, MAYA LEVENTER-ROBERTS, ITAMAR RAZ

Diabetes 2018;67(Supplement_1):185-LB

DOI: https://doi.org/10.2337/db18-185-LB

Published: 01 July 2018

View article

Meeting Abstracts

Intervention of the Flash Glucose Sensing Technology on Glycemic Control and Treatment Satisfaction in Patients with Type 2 Diabetes Treated Intensively by Insulin—A Randomized Controlled Trial

MARIANNA YARON, EYTAN ROITMAN, GENYA AHARON-HANANEL, ZOHAR LANDAU, TALI GANZ, MOSHE KARP, MAYA ISH-SHALOM, JOELLE SINGER, JULIO WAINSTEIN, SR., ITAMAR RAZ

Diabetes 2018;67(Supplement_1):908-P

DOI: https://doi.org/10.2337/db18-908-P

Published: 01 July 2018

View article

Meeting Abstracts

Feasibility of Creating a Diagnosis-Based Diabetic Foot Registry in a Large Health Care Provider

AVIVIT CAHN, TALYA ALTARAS, TAL AGAMI, SR., ORI LIRAN, COLETTE E. TOUATY, RENA POLLACK, ITAMAR RAZ, GABRIEL CHODICK, INBAR ZUCKER

Diabetes 2018;67(Supplement_1):636-P

DOI: https://doi.org/10.2337/db18-636-P

Published: 01 July 2018

View article

Meeting Abstracts

Use of a Machine Learning Algorithm Improves Prediction of Progression to Diabetes

AVIVIT CAHN, AVI SHOSHAN, TAL SAGIV, RACHEL YESHARIM, ITAMAR RAZ, RAN GOSHEN

Diabetes 2018;67(Supplement_1):1286-P

DOI: https://doi.org/10.2337/db18-1286-P

Published: 01 July 2018

View article

Journal Articles

Antidiabetic Effect of Interleukin-1β Antibody Therapy Through β-Cell Protection in the Cohen Diabetes-Sensitive Rat

Genya Aharon-Hananel, Anne Jörns, Sigurd Lenzen, Itamar Raz, Sarah Weksler-Zangen

Diabetes 2015;64(5):1780–1785

DOI: https://doi.org/10.2337/db14-1018

Published: 08 December 2014

View article

Journal Articles

Impaired Glucose-Stimulated Insulin Secretion Is Coupled With Exocrine Pancreatic Lesions in the Cohen Diabetic Rat

Sarah Weksler-Zangen, Itamar Raz, Sigurd Lenzen, Anne Jörns, Shira Ehrenfeld, Gail Amir, Andrei Oprescu, Yoram Yagil, Chana Yagil, David H. Zangen, Nurit Kaiser

Diabetes 2008;57(2):279–287

DOI: https://doi.org/10.2337/db07-0520

Published: 01 February 2008

View article

Includes: Supplementary data

Journal Articles

Nonproteinuric Diabetes-Associated Nephropathy in the Cohen Rat Model of Type 2 Diabetes

Chana Yagil, Adiel Barak, David Ben-Dor, Eliezer Rosenmann, Joel Bernheim, Mordechai Rosner, Yael Segev, Sarah Weksler-Zangen, Itamar Raz, Yoram Yagil

Diabetes 2005;54(5):1487–1496

DOI: https://doi.org/10.2337/diabetes.54.5.1487

Published: 01 May 2005

View article

Journal Articles

Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans

Mary C McGuire, Rose M Fields, Bulangu L Nyomba, Itamar Raz, Clifton Bogardus, Nicholas K Tonks, James Sommercorn

Diabetes 1991;40(7):939–942

DOI: https://doi.org/10.2337/diab.40.7.939

Published: 01 July 1991

View article

NARROW

1263-P: Adolescent Obesity and Incident Type 1 Diabetes in Young Adulthood

788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58

303-OR: Effect of Dapagliflozin on Risk for Fast Decline in EGFR: Analyses from the DECLARE-TIMI 58 Trial

1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

244-OR: Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

236-OR: Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial

The Association between Inpatient Hyperglycemia and Thirty-Day Mortality Is Modified by Type 2 Diabetes History

Intervention of the Flash Glucose Sensing Technology on Glycemic Control and Treatment Satisfaction in Patients with Type 2 Diabetes Treated Intensively by Insulin—A Randomized Controlled Trial

Feasibility of Creating a Diagnosis-Based Diabetic Foot Registry in a Large Health Care Provider

Use of a Machine Learning Algorithm Improves Prediction of Progression to Diabetes

Antidiabetic Effect of Interleukin-1β Antibody Therapy Through β-Cell Protection in the Cohen Diabetes-Sensitive Rat

Impaired Glucose-Stimulated Insulin Secretion Is Coupled With Exocrine Pancreatic Lesions in the Cohen Diabetic Rat

Nonproteinuric Diabetes-Associated Nephropathy in the Cohen Rat Model of Type 2 Diabetes

Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only